Advertisement
 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Oncology

   News

 

 Conferences


   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links
   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 
 

Back to Oncology Diseases

Li-Fraumeni syndrome

The Li-Fraumeni syndrome (LFS) is a rare, autosomal dominant cancer predisposition syndrome that is remarkable for the wide variety of cancer types involved, the young age at onset of malignancies, and the potential of multiple primary sites of cancer during the lifetime of affected individuals. Families meet the criteria for LFS with a minimum of 3 affected members.

Diagnosis

Clinical criteria

  • A proband diagnosed with sarcoma before age 45 years
  • A first-degree relative with any cancer diagnosed before age 45 years
  • Another first-degree or second-degree relative of the same genetic lineage with any cancer diagnosed before age 45 years or sarcoma at any age.

Lab diagnosis

DNA analysis: Evaluation for constitutional p53 mutation in cancer patients with family history or presentation suggestive of potential LFS cancer predisposition is warranted to aid in predicting future risk of other primary malignancies for the patient and other family members.

Although the majority of reported LFS-related p53 mutations occur in exons 5-8, optimal DNA analysis should include evaluation of the entire coding and noncoding portions of the gene (exons 1-11) by automated sequencing methods.

Since p53 mutations are constitutional (i.e. germline), DNA derived from any clinical source can potentially be evaluated. Peripheral blood leukocytes are the most easily obtained source, typically collected in citrate or heparin anticoagulant tubes.

advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


previous.gif (72x17 -- 347 bytes) next.gif (72x17 -- 277 bytes)

 

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright 2001-2012 DoctorsLounge. All rights reserved.